{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-017916","form_type":"8-K","ticker":"ATEC","cik":"0001350653","company_name":"Alphatec Holdings, Inc.","filed_at":"2023-05-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.534803+00:00","generated_at":"2026-06-15T21:18:49.632736+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Alphatec Q1 revenue up 54% to $109M; surgical revenue up 55%; adj EBITDA loss -$5M","bullets":["Total revenue $109M (+54% YoY); surgical revenue +55%; EOS revenue $15M.","GAAP gross margin 65%, non-GAAP 72%; GAAP operating loss ($40M); Adj. EBITDA loss ($5M).","FY2023 guidance reaffirmed: revenue $450M (28% growth), surgical +30%, EOS $57M; adjuvant EBITDA break-even expected.","Surgical volume +40%; avg revenue per procedure +11%; acquired navigation robotics platform."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-017916","json":"https://secwatch.observer/filing/0000950170-23-017916.json","markdown":"https://secwatch.observer/filing/0000950170-23-017916.md","text":"https://secwatch.observer/filing/0000950170-23-017916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/0000950170-23-017916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/atec-20230504.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-15T21:18:49.632736+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cc003e688cc3ce16d33ee4dfafce363b30ff2249","claim":"Alphatec Holdings, Inc. reported the quarter ended March 31, 2023 results: revenue $109 million. Guidance reaffirmed.","evidence_excerpt":"ATEC Reports First Quarter 2023 Financial Results Total revenue grew 54% to $109 million, including surgical revenue growth of 55% EOS revenue grew to $15 million Adjusted EBITDA margin improved 1,080 basis points year-over-year","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1350653/000095017023017916/0000950170-23-017916-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$109 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}